The Akkermansia Probiotic Boosted Insulin Sensitivity 29% in One Trial, But It's Not for Everyone
A single randomized controlled trial gave pasteurized Akkermansia muciniphila to overweight, insulin-resistant adults for three months. The results were genuinely impressive: insulin sensitivity improved roughly 29%, fasting insulin dropped, total cholesterol fell, and participants lost modest amounts of weight and fat mass. Short-term safety looked good. That's the best news this bacterium has going for it right now, and it's worth taking seriously. It's also worth taking carefully. That one trial is, so far, the only controlled human experiment with direct Akkermansia supplementation. The rest of the evidence comes from animal research and observational data, and some of it raises real concerns about who might be helped and who might be harmed.